GE forms colorectal cancer pact:
This article was originally published in Clinica
GE Healthcare has joined forces with the University of Oxford in the UK in a research programme designed to improve the diagnosis and treatment of colorectal cancer. The two-year collaboration, which will combine GE's knowledge of genomic and information technologies with the university's clinical data and medical and research expertise, will focus on improving colorectal cancer staging using imaging and genomic pathology; targeted therapy selection and efficacy assessment; and overall treatment monitoring. Results of the study could act as a model for other cancers and diseases.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.